Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CV · against 388 other Healthcare companies of similar size
Ranked #240 of 389 · scores higher than 12% of peers
Bars: peers in each 10-point band of the valuation score150 peers with a valuation score of 0–9, including CV · Click a bar to see the companies
Mainly because of its EBITDA yield, earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | CV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 374 reported | -6.7% | -0.3% | 36% | 30% | |
| EBITDA yieldHigher is better · 392 reported | -9.0% | 2.1% | 25% | 50% | |
| Free cash flow yieldHigher is better · 188 reported | -7.8% | -9.2% | 56% | 20% | |
| Book yieldHigher is better · 383 reported | 3.9% | 50.1% | 8% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 240 | 296M USD | 8 | 26 | |
| 240 | 560M USD | 8 | 42 | |
| 240 | 475M USD | 8 | 22 | |
| 240 | 365M USD | 8 | 41 | |
| 240 | 357M USD | 8 | 32 | |
| 240 | 635M USD | 8 | 39 | |
| 240 | 539M USD | 8 | 33 | |
| 240 | 647M USD | 8 | 40 | |
| 240 | 399M USD | 8 | 32 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score